Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003096 · ClinicalTrials.gov registry record
Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 88
- Enrollment target
NCT00003096: Completed study, sponsored by Children's Oncology Group.
NCT00003096 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003096 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
RATIONALE: Analyzing the number and structure of genes found in a child's cancer cells may help doctors improve methods of diagnosing and treating children with brain tumors. PURPOSE: This clinical trial is studying the number and structure of genes in cancer cells of children with brain tumors.
Primary Outcome
Estimate the frequency of specific chromosomal gains, losses and rearrangements in a series of infratentorial and supratentorial PNETS diagnosed in children
Interventions
- GENETIC cytogenetic analysis
- GENETIC fluorescence in situ hybridization
- GENETIC comparative genomic hybridization
- GENETIC DNA ploidy analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 1996-12 |
| Est. Completion | 2007-03 |
What the finished NCT00003096 record still lists
NCT00003096 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which cytogenetic analysis is the first listed.
NCT00003096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003096 about?
NCT00003096 is a clinical study titled "Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors". RATIONALE: Analyzing the number and structure of genes found in a child's cancer cells may help doctors improve methods of diagnosing and treating children with brain tumors. PURPOSE: This clinical trial is studying the number and structure of genes in cancer cells of children with brain tumors.
What is the current status of trial NCT00003096?
This trial is currently completed. The enrollment target is 88 participants. The study started on 1996-12. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00003096?
The interventions under investigation include: cytogenetic analysis (GENETIC), fluorescence in situ hybridization (GENETIC), comparative genomic hybridization (GENETIC), DNA ploidy analysis (GENETIC).
Who is sponsoring clinical trial NCT00003096?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia